G1GLP1 Note Applies to All countries

HomeGenericsMounjaro

GenericAll countries · Checked

Mounjaro Generic Name: Is There a Generic Mounjaro Yet?

The generic name of Mounjaro is tirzepatide. As of November 20, 2026, the US has approved no generic version, and four generic applications are waiting for FDA review.

Is there a generic Mounjaro?

Not yet. The generic name is tirzepatide, and no generic product is approved.

Generic nameTirzepatide

Brand namesMounjaro, Zepbound

US generic applications4 accepted for review, 0 approved

The maker is Eli Lilly. Based on the US and UK product labels and company announcements.

With no generic, you pay the brand price today.

See what Mounjaro costs in each country

In the US? See the Zepbound savings card and self-pay prices.

Generic nameIs there one?WhenZepboundBy countryDoseWhat generic meansMeanwhileOther drugsNewsFAQ

Mounjaro generic name

The generic name for Mounjaro is tirzepatide. It is the active substance listed in the product labels.

Mounjaro is a brand name. Tirzepatide is the medicine inside it.

Tirzepatide works on two hormone receptors, GIP and GLP-1, and it is injected under the skin once a week.

What the medicine does and who it is for is covered in Mounjaro (tirzepatide).

Is there a generic Mounjaro?

In the US, no generic tirzepatide is approved yet.

Generic makers have filed applications, and the FDA has accepted them for review. Accepted for review is not the same as approved.

US generic tirzepatide applications

Sandoz, announced June 29, 20262 applications accepted, autoinjector

Adalvo and Amneal, announced July 1, 20262 applications accepted, one for each brand

Approved generics0

Neither announcement gives an approval date or a launch date.

When will generic Mounjaro be available?

No date is set. A product can launch only after the FDA approves it.

The companies say they will sell their products if the FDA approves them. Amneal would lead sales for its pair of applications.

Until then, people in the US who take Mounjaro or Zepbound pay the brand price.

Prices differ a lot by country. The cost in each country is in Mounjaro price by country, and US self-pay options are in Zepbound savings card and LillyDirect prices.

Generic for Zepbound

Zepbound is also tirzepatide, so it has the same generic name and the same generic situation.

In the US, Mounjaro is the diabetes brand, and the same medicine is sold for weight management as Zepbound. The details are in generic tirzepatide.

Mounjaro by country

In the UK, Mounjaro is licensed for type 2 diabetes and for weight management. The weight management approval came on 8 November 2023.

In Canada, the weight management pen is sold as Zepbound KwikPen and the diabetes pen as Mounjaro.

The names change by country, but the ingredient is always tirzepatide. Searching for tirzepatide finds the same medicine under any brand.

UK prices are in Mounjaro price UK, and who can get it on the NHS is in Mounjaro on the NHS.

Will generic Mounjaro have the same dose?

With no approved generic, there is nothing to compare yet. The pending applications follow the approved autoinjector presentations and uses of the brands.

Mounjaro itself comes in doses from 2.5 mg to 15 mg once a week. The full schedule is in Mounjaro dosing.

Where and how to inject it is in Mounjaro injection sites.

What a generic Mounjaro would be

A generic is a medicine approved as the same as the brand: the same active ingredient, the same strength and the same way of giving it. Only the name and the maker differ.

An approved generic Mounjaro would also be weekly tirzepatide by injection. The pending applications are for autoinjector pens.

The uses listed in the applications follow the brands, which include type 2 diabetes and chronic weight management.

Even after a generic is approved, your prescriber chooses the product you use. Do not switch products or change your dose on your own.

What to do while there is no generic

If you already take Mounjaro or Zepbound, keep taking it as prescribed. Waiting for a generic is not a reason to skip a weekly dose.

If you miss a dose, the rules and the time the medicine stays in your body are in tirzepatide half-life.

If cost is the worry, start with the price pages and the coverage pages. In the UK the NHS rules change the cost a lot, and in the US the manufacturer program rules do.

The US picture for the weight loss brand is in generic tirzepatide, and the medicine itself is in Zepbound (tirzepatide).

Generic versions of other weight loss drugs

Unlike tirzepatide, semaglutide and liraglutide already have generic versions approved in some countries.

Semaglutide is covered in generic semaglutide, with separate pages for generic Ozempic and the Wegovy generic name.

The wider picture is in generic GLP-1 drugs.

Mounjaro news and approvals

Approval dates for Mounjaro and Zepbound are collected in tirzepatide FDA approval.

This page is updated when the FDA approves a generic or when the application status changes.

Mounjaro generic FAQ

What is the generic name for Mounjaro?

Tirzepatide. Mounjaro and Zepbound both contain it.

Can I buy generic Mounjaro?

No. There is no approved generic to buy yet, so the brand is the only approved product.

Are Mounjaro and Zepbound the same medicine?

Yes. Both are tirzepatide in the same doses. In the US they carry different names because they are approved for different uses.

Will the price drop when a generic arrives?

Nobody can say yet. A generic price is set only when a product is approved and launched.

Keep reading

Mounjaro price by country

Mounjaro price UK: cost of each dose

Mounjaro dosing chart

Generic tirzepatide

Generic semaglutide

Tirzepatide half-life

This page follows the official product labels and company announcements, and it is updated when the status changes. See how we check our pages.

Update log

: First published.

Sources

Mounjaro KwikPen Summary of Product Characteristics (electronic medicines compendium, UK).

Mounjaro US prescribing information (Eli Lilly).

MHRA authorises Mounjaro for weight management (UK government).

Adalvo and Amneal announce FDA acceptance of generic tirzepatide applications, July 1, 2026.

FDA accepts Sandoz applications for generic tirzepatide (Drug Topics, July 3, 2026, reporting the Sandoz announcement of June 29, 2026).

GLP1 Note is an independent information site. Your own treatment is decided by your prescriber.